InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: jeffqdhsr post# 6700

Monday, 07/31/2017 8:39:28 PM

Monday, July 31, 2017 8:39:28 PM

Post# of 14871
Jeff, according to Biotech Due Diligence it appears that The July 2011 Leerink Swann analyst report was of the impression that Efficacy was being captured in the safety study. Unfortunately the original report is no longer available.

Leerink Swann

This is further supported by the American Heart Journal "A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder" in January 2012 listing Dr Snabes and Joanne Zborowski (Biosante) as authors.

AJH arrticle

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News